{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:08:44Z","timestamp":1789960124134,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.mayocp.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:56:02Z","timestamp":1561168562000},"page":"1834-1839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oncolytic Measles Virotherapy and Opposition to Measles Vaccination"],"prefix":"10.1016","volume":"94","author":[{"given":"Stephen J.","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusica","family":"Babovic-Vuksanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bexon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-3004","authenticated-orcid":false,"given":"David","family":"Dingli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Deyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Galanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minetta C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-9451","authenticated-orcid":false,"given":"Miguel","family":"Mu\u00f1oz-Al\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanner C.","family":"Miest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-4635","authenticated-orcid":false,"given":"Julian R.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott H.","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandakumar","family":"Packiriswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Peikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Raffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-1282","authenticated-orcid":false,"given":"Frits","family":"Van Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Ungerechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-7721","authenticated-orcid":false,"given":"Kah-Whye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2019.05.006_bib1","unstructured":"World Health Organization. Measles. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles. Published May 9, 2019. Accessed May 24, 2019"},{"key":"10.1016\/j.mayocp.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","article-title":"Measles","volume":"2","author":"Rota","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.mayocp.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapediatrics.2016.1787","article-title":"Measles and measles vaccination: a review","volume":"170","author":"Bester","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"10111","key":"10.1016\/j.mayocp.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00430-016-0451-4","article-title":"Eradication of measles: remaining challenges","volume":"205","author":"Holzmann","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.mayocp.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2741\/2767","article-title":"Measles vaccines","volume":"13","author":"Griffin","year":"2008","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.mayocp.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/hv.34298","article-title":"Measles virus","volume":"11","author":"Naim","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.mayocp.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MD.0b013e3182a713c2","article-title":"Severe measles infection: the spectrum of disease in 36 critically ill adult patients","volume":"92","author":"Rafat","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.mayocp.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/GRF.0b013e31824df256","article-title":"Measles, mumps, and rubella","volume":"55","author":"White","year":"2012","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.05.006_bib10","first-page":"797","article-title":"Measles in pregnancy: a descriptive study of 58 cases","volume":"82","author":"Eberhart-Phillips","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mayocp.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-065X.2010.00925.x","article-title":"Measles virus-induced suppression of immune responses","volume":"236","author":"Griffin","year":"2010","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.mayocp.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/v8080210","article-title":"Measles virus host invasion and pathogenesis","volume":"8","author":"Laksono","year":"2016","journal-title":"Viruses"},{"issue":"6235","key":"10.1016\/j.mayocp.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/hcu113","article-title":"Measles-induced encephalitis","volume":"108","author":"Fisher","year":"2014","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.spen.2012.02.003","article-title":"Measles virus and associated central nervous system sequelae","volume":"19","author":"Buchanan","year":"2012","journal-title":"Semin Pediatr Neurol"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"i22","DOI":"10.1136\/jnnp.2003.034256","article-title":"Inflammatory\/post-infectious encephalomyelitis","volume":"75","author":"Bennetto","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/cix302","article-title":"Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated","volume":"65","author":"Wendorf","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2, suppl","key":"10.1016\/j.mayocp.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2105\/AJPH.52.Suppl_2.5","article-title":"The development and evaluation of an attenuated measles virus vaccine","volume":"52","author":"Katz","year":"1962","journal-title":"Am J Public Health Nations Health"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1542\/peds.2011-1430","article-title":"The first measles vaccine","volume":"128","author":"Baker","year":"2011","journal-title":"Pediatrics"},{"issue":"15","key":"10.1016\/j.mayocp.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.2015.3077","article-title":"Autism occurrence by MMR vaccine status among US children with older siblings with and without autism","volume":"313","author":"Jain","year":"2015","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.mayocp.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.vaccine.2014.04.085","article-title":"Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies","volume":"32","author":"Taylor","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.mayocp.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jmv.20585","article-title":"Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK","volume":"78","author":"Afzal","year":"2006","journal-title":"J\u00a0Med Virol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1542\/peds.107.5.e84","article-title":"Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000","volume":"107","author":"Halsey","year":"2001","journal-title":"Pediatrics"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.vaccine.2017.10.065","article-title":"Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: background and summary","volume":"36","author":"Orenstein","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.mayocp.2019.05.006_bib25","unstructured":"Centers for Disease Control and Prevention. Measles, Mumps, and Rubella (MMR) Vaccination: What Everyone Should Know. https:\/\/www.cdc.gov\/vaccines\/vpd\/mmr\/public\/index.html. Accessed May 24, 2019."},{"issue":"11","key":"10.1016\/j.mayocp.2019.05.006_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/cid\/cix639","article-title":"Effectiveness of measles vaccination and immune globulin post-exposure prophylaxis in an outbreak setting\u2014New York City, 2013","volume":"65","author":"Arciuolo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2019.05.006_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.mayocp.2019.05.006_bib28","first-page":"13","article-title":"Appropriate age for measles vaccination in the United States","volume":"65","author":"Orenstein","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"10","key":"10.1016\/j.mayocp.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.3390\/v9100265","article-title":"A\u00a0recombinant measles vaccine with enhanced resistance to passive immunity","volume":"9","author":"Julik","year":"2017","journal-title":"Viruses"},{"issue":"47","key":"10.1016\/j.mayocp.2019.05.006_bib30","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2015.07.085","article-title":"Maternal antibodies and infant immune responses to vaccines","volume":"33","author":"Edwards","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mayocp.2019.05.006_bib31","unstructured":"Mu\u00f1oz-Al\u00eda M-\u00c1, Bah ES, Russell SJ. Serotypic evolution of measles is constrained by multiple codominant B-cell epitopes on its surface glycoproteins. Cell. In press."},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/infdis\/jix175","article-title":"Approaches to vaccination among populations in areas of conflict","volume":"216","author":"Nnadi","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2019.05.006_bib33","first-page":"104","article-title":"Exploring the reasons behind parental refusal of vaccines","volume":"21","author":"McKee","year":"2016","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.mayocp.2019.05.006_bib34","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.mayocp.2015.09.006","article-title":"Vaccine hesitancy","volume":"90","author":"Jacobson","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"7715","key":"10.1016\/j.mayocp.2019.05.006_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(71)92086-1","article-title":"Regression of Burkitt's lymphoma in association with measles infection [letter]","volume":"2","author":"Bluming","year":"1971","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mayocp.2019.05.006_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"Russell","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.mayocp.2019.05.006_bib37","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/leu.2017.120","article-title":"Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma","volume":"31","author":"Dispenzieri","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.mayocp.2019.05.006_bib38","first-page":"213","article-title":"Measles virus for cancer therapy","volume":"330","author":"Russell","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.05.006_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.05.006_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2011.12.002","article-title":"Targeted entry of enveloped viruses: measles and herpes simplex virus I","volume":"2","author":"Navaratnarajah","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.05.006_bib41","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-11-4558","article-title":"Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in\u00a0vivo and targets\u00a0interferon-resistant tumor cells","volume":"106","author":"Heinzerling","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.006_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","article-title":"Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer","volume":"70","author":"Galanis","year":"2010","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.mayocp.2019.05.006_bib43","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djy033","article-title":"Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy","volume":"110","author":"Kurokawa","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.mayocp.2019.05.006_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Galanis","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.mayocp.2019.05.006_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1479-5876-11-20","article-title":"Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer","volume":"11","author":"Mader","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"23","key":"10.1016\/j.mayocp.2019.05.006_bib46","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1158\/1078-0432.CCR-09-1292","article-title":"Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model","volume":"15","author":"Mader","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mayocp.2019.05.006_bib47","doi-asserted-by":"crossref","first-page":"e52306","DOI":"10.1371\/journal.pone.0052306","article-title":"Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies","volume":"8","author":"Lech","year":"2013","journal-title":"PloS One"},{"issue":"3-4","key":"10.1016\/j.mayocp.2019.05.006_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41417-018-0042-1","article-title":"Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference","volume":"26","author":"Dyer","year":"2019","journal-title":"Cancer Gene Ther"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:30:32Z","timestamp":1758418232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619304628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0025619619304628"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.006","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic Measles Virotherapy and Opposition to Measles Vaccination","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}